Eagle Fights FDA's DC Circ. Bid To Undo Orphan Drug Win
Eagle Pharmaceuticals has urged the DC Circuit to cement a recent ruling that gave marketing exclusivity to multiple manufacturers of a drug that treats the same rare medical condition, saying the...To view the full article, register now.
Already a subscriber? Click here to view full article